Background When three SARS-CoV-2 vaccines came to market in Europe and North
America in the winter of 2020–2021, distribution networks were in a race against a major …

Purpose: Sequential treatment with targeted therapies can result in complex combinations
of resistance mutations in drug targets. This mutational complexity has spurred the …

State-level reopenings in late spring 2020 facilitated the resurgence of severe acute
respiratory syndrome coronavirus 2 transmission. Here, we analyze age-structured case, …

Rationally designing drugs that last longer in the face of biological evolution is a critical
objective of drug discovery. However, this goal is thwarted by the diversity and stochasticity of …

Although rarely used in nature, fluorine has emerged as an important elemental ingredient
in the design of proteins with altered folding, stability, oligomerization propensities, and …

As three SARS-CoV-2 vaccines come to market in Europe and North America in the winter of
2020–2021, distribution networks will be in a race against a major epidemiological wave of …

Drug repositioning seeks to leverage existing clinical knowledge to identify alternative clinical
settings for approved drugs. However, repositioning efforts fail to demonstrate improved …

Introduction Modern targeted cancer therapies are carefully crafted small molecules. These
exquisite technologies exhibit an astonishing diversity of observed failure modes (drug …

Theoretical treatments of evolutionary dynamics tend to model the probability that a single “resistant”
species will arise in a population. However, experimental studies have identified a …

Estimating an infectious disease attack rate requires inference on the number of reported
symptomatic cases of a disease, the number of unreported symptomatic cases, and the number …